Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0Frontiers in Neuroscience

Apparent dissociation between hemodynamic and neurochemical responses during chemogenetic modulation of cortical circuits in rats

  1. 1Laboratory for Functional and Metabolic Imaging, Ecole Polytechnique Fédérale de Lausanne
  2. 2Danish Research Centre for Magnetic Resonance, Department of Radiology and Nuclear Medicine, Copenhagen University Hospital - Amager and Hvidovre

Abstract

Introduction: Chemogenetic tools such as Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) provide a powerful means to causally manipulate defined neuronal populations in vivo . While chemogenetic fMRI studies have consistently demonstrated robust hemodynamic responses following circuit perturbation, considerably less is known about the accompanying metabolic consequences. Functional magnetic resonance spectroscopy (fMRS) offers the potential to probe these neurochemical processes, yet the relationship between hemodynamic and metabolic responses remains poorly understood. Here, we combined chemogenetics, pharmacological fMRI (Ph-fMRI), and proton magnetic resonance spectroscopy ( ¹ H-MRS/fMRS) at 7 T to investigate the temporal evolution of metabolic and hemodynamic responses in the rat motor cortex.

Methods: Female Fischer rats received viral injections in the motor cortex to express either a pan-neuronal hM3D(Gq) DREADD construct (hSyn-hM3D(Gq)) or an interneuron-targeted construct (hDlx-hM3D(Gq)). Ph-fMRI, fMRS, and ¹ H-MRS measurements were performed before, during, and following systemic administration of clozapine-N-oxide (CNO, 1 mg/kg). Functional MRS was acquired during the acute response phase (0–60 min post-injection), while conventional ¹ H-MRS measurements were obtained at a delayed time point (70 min post-injection).

Results: Chemogenetic modulation produced robust and opposing hemodynamic responses. Pan-neuronal activation elicited focal positive BOLD responses (+3.5 ± 1.5%), whereas interneuron-targeted activation generated significant negative BOLD responses (−3.3 ± 0.8%). In contrast, acute fMRS measurements revealed no significant changes in Glx or GABA concentrations during the first hour following CNO administration, despite the presence of strong hemodynamic effects. However, delayed metabolic differences were detected at the static ¹ H-MRS time point acquired 70 min after CNO administration. Relative to Sham animals, the ipsilateral motor cortex of pan-neuronal DREADD animals showed higher GABA (+14.4%) and total choline compound concentrations (+57.8%), whereas interneuron-targeted DREADD animals exhibited lower Glx (−15.6%), total NAA (−16.9%), glucose (−25.9%), and total creatine (−25.4%). These delayed effects emerged after the period of peak hemodynamic responses and were not accompanied by significant acute fMRS changes.

Conclusion: Chemogenetic perturbation of cortical circuits produced robust hemodynamic responses but more subtle and temporally complex metabolic effects. The absence of detectable acute changes in Glx and GABA despite strong BOLD responses, together with the emergence of delayed neurochemical alterations, highlights the challenges of interpreting metabolic signals in relation to circuit activity.

Related

  1. Descending Pain Modulation Across Pain States: Circuit Mechanisms, Neurochemical Plasticity, and Translational Perspectives
    Armando Almeida, Isaura Tavares
    Neurology internationalPeer-reviewedCC BYFull textPhysiologyEurope PMCDOAJ
  2. Cardiorenal Syndrome: From Hemodynamic and Humoral Pathophysiology to New Frontiers in Modulation and Enabling Therapy—Part 2
    Alfredo Mauriello, Valeria Cetoretta, Carmen Del Giudice +7
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Cardiorenal Syndrome: From Hemodynamic and Humoral Pathophysiology to New Frontiers in Modulation and Enabling Therapy—Part 1
    Alfredo Mauriello, Valeria Cetoretta, Carmen Del Giudice +7
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Hemodynamic Responses to Cold Water Ingestion During Head-Up Tilt
    S. Kubota, K. Yamauchi, Y. Endo +1
    medRxivPreprintCC BY-NC-NDFull textSurgery & anaesthesiamedRxiv
  5. Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer
    Varun Nandakumar, Georges Gebrael, Neeraj Agarwal
    The OncologistPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
BibTeX
@article{anvarivind2026apparent,
  title = {{Apparent dissociation between hemodynamic and neurochemical responses during chemogenetic modulation of cortical circuits in rats}},
  author = {Fatemeh Anvari-Vind and Nathalie Just},
  journal = {Frontiers in Neuroscience},
  year = {2026},
  month = oct,
  doi = {10.3389/fnins.2026.1916498},
  url = {https://www.frontiersin.org/articles/10.3389/fnins.2026.1916498/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Apparent dissociation between hemodynamic and neurochemical responses during chemogenetic modulation of cortical circuits in rats
AU  - Fatemeh Anvari-Vind
AU  - Nathalie Just
PY  - 2026
DA  - 2026/10/08
JO  - Frontiers in Neuroscience
DO  - 10.3389/fnins.2026.1916498
UR  - https://www.frontiersin.org/articles/10.3389/fnins.2026.1916498/full
AB  - Introduction: Chemogenetic tools such as Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) provide a powerful means to causally manipulate defined neuronal populations in vivo . While chemogenetic fMRI studies have consistently demonstrated robust hemodynamic responses following circuit perturbation, considerably less is known about the accompanying metabolic consequences. Functional magnetic resonance spectroscopy (fMRS) offers the potential to probe these neurochemical processes, yet the relationship between hemodynamic and metabolic responses remains poorly understood. Here, we combined chemogenetics, pharmacological fMRI (Ph-fMRI), and proton magnetic resonance spectroscopy ( ¹ H-MRS/fMRS) at 7 T to investigate the temporal evolution of metabolic and hemodynamic responses in the rat motor cortex.  Methods: Female Fischer rats received viral injections in the motor cortex to express either a pan-neuronal hM3D(Gq) DREADD construct (hSyn-hM3D(Gq)) or an interneuron-targeted construct (hDlx-hM3D(Gq)). Ph-fMRI, fMRS, and ¹ H-MRS measurements were performed before, during, and following systemic administration of clozapine-N-oxide (CNO, 1 mg/kg). Functional MRS was acquired during the acute response phase (0–60 min post-injection), while conventional ¹ H-MRS measurements were obtained at a delayed time point (70 min post-injection).  Results: Chemogenetic modulation produced robust and opposing hemodynamic responses. Pan-neuronal activation elicited focal positive BOLD responses (+3.5 ± 1.5%), whereas interneuron-targeted activation generated significant negative BOLD responses (−3.3 ± 0.8%). In contrast, acute fMRS measurements revealed no significant changes in Glx or GABA concentrations during the first hour following CNO administration, despite the presence of strong hemodynamic effects. However, delayed metabolic differences were detected at the static ¹ H-MRS time point acquired 70 min after CNO administration. Relative to Sham animals, the ipsilateral motor cortex of pan-neuronal DREADD animals showed higher GABA (+14.4%) and total choline compound concentrations (+57.8%), whereas interneuron-targeted DREADD animals exhibited lower Glx (−15.6%), total NAA (−16.9%), glucose (−25.9%), and total creatine (−25.4%). These delayed effects emerged after the period of peak hemodynamic responses and were not accompanied by significant acute fMRS changes.  Conclusion: Chemogenetic perturbation of cortical circuits produced robust hemodynamic responses but more subtle and temporally complex metabolic effects. The absence of detectable acute changes in Glx and GABA despite strong BOLD responses, together with the emergence of delayed neurochemical alterations, highlights the challenges of interpreting metabolic signals in relation to circuit activity.
SN  - 1662-453X
SN  - 1662-4548
ER  -